Sanofi plans to buy more shares in Regeneron

02/12/2013 | Reuters

Sanofi plans to increase its stake in longtime drug development partner Regeneron Pharmaceuticals by purchasing shares on the open market. Sanofi holds a 16.7% stake in Regeneron. An agreement gives Sanofi the right to boost its stake in Regeneron to up to 30%. The two companies are jointly developing drugs for rheumatoid arthritis and cholesterol.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN